Effectiveness of Nateglinide on Insulin Secretion from Rat Pancreatic Islets
Author Information
Author(s): SHILING HU, SHUYA WANG, BETH E. DUNNING
Primary Institution: Novartis Institute for Biomedical Research
Hypothesis
Nateglinide retains the ability to stimulate insulin secretion from pancreatic islets desensitized to sulfonylureas.
Conclusion
Nateglinide is effective in stimulating insulin secretion from islets that have been desensitized by sulfonylureas.
Supporting Evidence
- Nateglinide maintained insulin secretion in islets desensitized to sulfonylureas.
- Islets pretreated with sulfonylureas showed reduced response to other agents but not to nateglinide.
- The study used a static incubation method to evaluate insulin secretion.
- Statistical analysis indicated significant differences in insulin secretion responses.
Takeaway
Nateglinide can help the pancreas release insulin even when other diabetes medications have made it less responsive.
Methodology
The study involved static incubation of rat pancreatic islets pretreated with sulfonylureas to assess their insulin secretion response to nateglinide and other agents.
Limitations
The study was conducted in vitro, which may not fully represent in vivo conditions.
Participant Demographics
Normal fed male Sprague Dawley rats (250-275g)
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website